Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_05-cv-00660/USCOURTS-caed-2_05-cv-00660-2/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

REED

S

MIT

H LLP

A limited liability partnership formed in the State of Delaware

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

 

Michael K. Brown (CSBN 104252) 

Thomas J. Yoo (CSBN 175118) 

REED SMITH LLP 

355 South Grand Avenue, Suite 2900 

Los Angeles, CA 90071 

Telephone: (213) 457-8000 

Facsimile: (213) 457-8080 

Steven J. Boranian (CSBN 174183) 

Susan B. Altman (CSBN 230227) 

REED SMITH LLP 

Two Embarcadero Center, Suite 2000 

San Francisco, CA 94111 

Telephone: (415) 543-8700 

Facsimile: (415) 391-8269 

Attorneys for Defendant 

Merck & Co., Inc 

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

LARRY GRAHAM, 

Plaintiff, 

vs. 

MERCK & COMPANY, INC.; a corporation; 

MCKESSON CORPORATION, a corporation, 

and DOES 1-100, inclusive, 

Defendants. 

Case No.: 2:05-cv-00660-MCE-PAN 

STIPULATION AND [PROPOSED]

ORDER STAYING PROCEEDINGS 

Hon. Morrison C. England Jr. 

Case 2:05-cv-00660-MCE -PAN Document 33 Filed 05/12/05 Page 1 of 3
REED

S

MIT

H LLP

A limited liability partnership formed in the State of Delaware

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

- 2 - 

The parties, by and through their counsel, stipulate to and respectfully request a stay of all 

proceedings in this action pending the transfer of this case to In re VIOXX Products Liability 

Litigation, MDL No. 1657. This stipulation is applicable solely to Plaintiff Graham’s case and shall 

have no effect on future proceedings between Defendant Merck & Co., Inc. (“Merck”) and 

Plaintiff’s counsel. 

Plaintiff Larry Graham alleges personal injuries that he attributes to the prescription drug 

VIOXX®. Defendant Merck & Co., Inc. (“Merck”) manufactured and distributed VIOXX®, but 

voluntarily withdrew VIOXX® from the market on September 30, 2004. 

On February 16, 2005, the Judicial Panel on Multidistrict Litigation (“JPML”) issued an 

order transferring 148 VIOXX®-related cases to the United States District Court for the Eastern 

District of Louisiana for coordinated pretrial proceedings under 28 U.S.C. § 1407. Merck intends to 

seek the transfer of this action to that Multidistrict Litigation, In re VIOXX Products Liability 

Litigation, MDL No. 1657, and has provided the JPML with notice of this action pursuant to the 

procedure for "tag along" actions set forth in the rules of the JPML. 

Based on the foregoing, the parties respectfully request that the Court stay this action 

pending its transfer to MDL No. 1657. 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

/// 

Case 2:05-cv-00660-MCE -PAN Document 33 Filed 05/12/05 Page 2 of 3
REED

S

MIT

H LLP

A limited liability partnership formed in the State of Delaware

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

- 3 - 

DATED: [May 9, 2005] 

REED SMITH LLP 

By /s/ Susan B. Altman for Steven J. Boranian

Steven J. Boranian 

Attorneys for Defendant 

Merck & Co., Inc. 

DATED: [May 6, 2005] 

ALEXANDER HAWES & AUDET LLP 

By /s/ Susanne N. Scovern 

Susanne N. Scovern 

Attorneys for Plaintiff 

Larry Graham 

ORDER

Having considered the foregoing stipulation and good cause appearing therefore, IT IS SO 

ORDERED that this action is stayed pending transfer of this case to In Re VIOXX Products Liability 

Litigation, MDL No. 1657. Defendant Merck’s Motion to Stay and Plaintiff Larry Graham’s 

Remand Motion, scheduled to be heard on May 16, 2005, are now off calendar. 

DATED: May 12, 2005 

__________________________________ 

MORRISON C. ENGLAND, JR 

UNITED STATES DISTRICT JUDGE 

Case 2:05-cv-00660-MCE -PAN Document 33 Filed 05/12/05 Page 3 of 3